SignatureFD’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $24K | Buy |
659
+80
| +14% | +$2.91K | ﹤0.01% | 1964 |
|
|
2025
Q1 | $21K | Sell |
579
-256
| -31% | -$9.27K | ﹤0.01% | 2025 |
|
|
2024
Q4 | $35.1K | Sell |
835
-40
| -5% | -$1.68K | ﹤0.01% | 1751 |
|
|
2024
Q3 | $48.6K | Buy |
875
+112
| +15% | +$6.22K | ﹤0.01% | 1585 |
|
|
2024
Q2 | $31.4K | Buy |
763
+24
| +3% | +$986 | ﹤0.01% | 1747 |
|
|
2024
Q1 | $34.5K | Buy |
739
+62
| +9% | +$2.9K | ﹤0.01% | 1735 |
|
|
2023
Q4 | $32.4K | Sell |
677
-240
| -26% | -$11.5K | ﹤0.01% | 1680 |
|
|
2023
Q3 | $32.7K | Sell |
917
-104
| -10% | -$3.71K | ﹤0.01% | 1607 |
|
|
2023
Q2 | $47.1K | Buy |
1,021
+305
| +43% | +$14.1K | ﹤0.01% | 1467 |
|
|
2023
Q1 | $28.7K | Sell |
716
-746
| -51% | -$29.9K | ﹤0.01% | 1674 |
|
|
2022
Q4 | $67.7K | Buy |
1,462
+862
| +144% | +$39.9K | ﹤0.01% | 1198 |
|
|
2022
Q3 | $25K | Buy |
600
+361
| +151% | +$15K | ﹤0.01% | 1636 |
|
|
2022
Q2 | $14K | Buy |
239
+98
| +70% | +$5.74K | ﹤0.01% | 1956 |
|
|
2022
Q1 | $10K | Buy |
141
+47
| +50% | +$3.33K | ﹤0.01% | 2157 |
|
|
2021
Q4 | $8K | Buy |
94
+67
| +248% | +$5.7K | ﹤0.01% | 2226 |
|
|
2021
Q3 | $2K | Buy |
27
+21
| +350% | +$1.56K | ﹤0.01% | 2689 |
|
|
2021
Q2 | $1K | Sell |
6
-11
| -65% | -$1.83K | ﹤0.01% | 2791 |
|
|
2021
Q1 | $2K | Sell |
17
-5
| -23% | -$588 | ﹤0.01% | 2511 |
|
|
2020
Q4 | $3K | Buy |
22
+16
| +267% | +$2.18K | ﹤0.01% | 2158 |
|
|
2020
Q3 | $0 | Buy |
+6
| New | – | ﹤0.01% | 2705 |
|
|
2018
Q4 | – | Sell |
-1
| Closed | – | – | 2040 |
|
|
2018
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 1981 |
|
|
2018
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 1961 |
|
|
2018
Q1 | $0 | Buy |
+1
| New | – | ﹤0.01% | 1761 |
|